Patent: 9,453,015
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 9,453,015
Title: | Pyrazole derivative |
Abstract: | It has been desired to develop a pharmaceutical composition, which is used in agents for preventing and/or treating various diseases related to PDE10 (e.g. mental disorder and neurodegenerative disorder). The present invention provides: compounds having PDE10 inhibitory effect, in particular, compounds having a 4-heteroarylpyrazole-5-carboxylic acid amide structure represented by the following formula (I), or their pharmaceutically acceptable salts, or their solvates; pharmaceutical compositions comprising, as active ingredients, the compounds, or their pharmaceutically acceptable salts, or their solvates; and medical use of the compounds, or their pharmaceutically acceptable salts, or their solvates. ##STR00001## |
Inventor(s): | Okano; Akihiro (Tokyo, JP), Saitoh; Fumihiko (Tokyo, JP) |
Assignee: | MOCHIDA PHARMACEUTICAL CO., LTD. (Tokyo, JP) |
Application Number: | 14/631,345 |
Patent Claims: | see list of patent claims |
Details for Patent 9,453,015
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | See Plans and Pricing | 2033-02-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |